ÖZET
Fibromiyalji (FM), kronik yaygın ağrının yanı sıra yorgunluk, kötü uyku kalitesi ve çok sayıda eşlik eden hastalıkla karakterizedir. Dünya çapında yaygınlığı %2,7 civarındadır ve kadınlarda daha sık görülür. Epidemiyoloji ve patofizyolojisi kesin olarak açıklanamamakla birlikte çeşitli etmenlerin birliktelik gösterdiği bilinmektedir. Hastalığın tanısı için yıllar boyunca çeşitli kriterleri içeren kılavuzlar oluşturulmuştur. FM tedavisinde amaçlanan hastanın yaşam kalitesini artırmak, semptomları mümkün olduğunca azaltmaktır. FM’de tedavinin başarısı sınırlıdır. Birçok hasta diyet ve yaşam tarzı değişiklikleri de dahil olmak üzere alternatif tedavi yöntemleri aramaktadır. Bu noktada son zamanlarda araştırmaların odağında tıbbi beslenme tedavileri ve fitoterapi ürünleri yer almaktadır. Fitoterapi ürünleri tek başına ya da kombine şekilde diğer tedavi yöntemlerine eklenebilmekte ve tedavinin başarısını artırabilmektedir. Bu yazıda FM sendromunun epidemiyolojisi, patofizyolojisi, tanı yöntemleri, tedavide kullanılan farmakolojik ve non-farmakolojik yöntemlere değinilecek ve en çok kullanım alanı bulan fitoterapötik ürünler ele alınacaktır.
References
1
Jahan F, Nanji K, Qidwai W, Qasim R. Fibromyalgia syndrome: an overview of pathophysiology, diagnosis and management. Oman Med J 2012;27:192-5.
2
Al Sharie S, Varga SJ, Al-Husinat L, Sarzi-Puttini P, Araydah M, Bal’awi BR, et al. Unraveling the Complex Web of Fibromyalgia: A Narrative Review. Medicina (Kaunas) 2024;60:272.
3
Clauw DJ. Fibromyalgia: an overview. Am J Med 2009;122:S3-13.
4
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
5
Wolfe F, Rasker JJ. The Evolution of Fibromyalgia, Its Concepts, and Criteria. Cureus 2021;13:e20010.
6
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152:S2-15.
7
Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed 2017;57:356-63.
8
Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17:356.
9
Yalvaç T. Fizik tedavi ve rehabilitasyon polikliniğine başvuran fibromiyalji tanılı hastalarda bedensel belirti bozukluğu sıklığı ve d tipi kişilik özelliği ile birlikteliği (thesis). Konya: Necmettin Erbakan University. 2023.
10
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
11
Bazzichi L, Giacomelli C, Consensi A, Atzeni F, Batticciotto A, Di Franco M, et al. One year in review 2016: fibromyalgia. Clin Exp Rheumatol 2016;34:S145-9.
12
Gür A. Fibromiyaljide Etiyopatogenez. Türk Fiz Tıp Rehab Derg 2008:54 Özel Sayı 1;4-11.
13
Ramanathan S, Panksepp J, Johnson B. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option? Psychosomatics 2012;53:591-4.
14
Dutta D, Brummett CM, Moser SE, Fritsche LG, Tsodikov A, Lee S, et al. Heritability of the Fibromyalgia Phenotype Varies by Age. Arthritis Rheumatol 2020;72:815-23.
15
Kato K, Sullivan PF, Evengård B, Pedersen NL. Chronic widespread pain and its comorbidities: a population-based study. Arch Intern Med 2006;166:1649-54.
16
Erşan E, Şencan D, Gürbüz C, Deveci H, Karadağ A. Fibromiyaljili hastaların anksiyete düzeylerinin incelenmesi. Literatür Sempozyum Dergisi 2014;1:32-9.
17
Harris RE, Clauw DJ. Newer treatments for fibromyalgia syndrome. Ther Clin Risk Manag 2008;4:1331-42.
18
Mickle AD, Shepherd AJ, Mohapatra DP. Sensory TRP channels: the key transducers of nociception and pain. Prog Mol Biol Transl Sci 2015;131:73-118.
19
D’agnelli S, Arendt-Nielsen L, Gerra MC, Zatorri K, Boggiani L, Baciarello M, et al. Fibromyalgia: Genetics and epigenetics insights may provide the basis for the development of diagnostic biomarkers. Mol Pain 2019;15:1744806918819944.
20
Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I, et al. The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum 2013;65:1122-8.
21
Yunus MB. The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 2001;3:128-34.
22
Bethea CL, Pecins-Thompson M, Schutzer WE, Gundlah C, Lu ZN. Ovarian steroids and serotonin neural function. Mol Neurobiol 1998;18:87-123.
23
Dufourny L, Warembourg M. Estrogen modulation of neuropeptides: somatostatin, neurotensin and substance P, in the ventrolateral and arcuate nuclei of the female guinea pig. Neurosci Res 1999;33:223-8.
24
Gur A, Cevik R, Nas K, Colpan L, Sarac S. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 2004;6:R232-8.
25
Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
26
Becker S, Schweinhardt P. Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat 2012;2012:741746.
27
Petersel DL, Dror V, Cheung R. Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res 2011;89:29-34.
28
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat 2012;2012:426130.
29
Björkander S, Ernberg M, Bileviciute-Ljungar I. Reduced immune system responsiveness in fibromyalgia—A pilot study. Clin Immunol Commun 2022;2:46-53.
30
Kılıçarslan A, Yurdakul FG, Bodur H. Diagnosing fibromyalgia in rheumatoid arthritis: The importance of assessing disease activity. Turk J Phys Med Rehabil 2018,15;64:133-9.
31
Goldenberg DL. Do infections trigger fibromyalgia? Arthritis Rheum 1993;36:1489-92.
32
Dell’Osso L, Carmassi C, Consoli G, Conversano C, Ramacciotti CE, Musetti L, et al. Lifetime post-traumatic stress symptoms are related to the health-related quality of life and severity of pain/fatigue in patients with fibromyalgia. Clin Exp Rheumatol 2011;29:S73-8.
33
Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al. Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 2003;48:2916-22.
34
Siracusa R, Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci 2021;9;22:3891.
35
Anch AM, Lue FA, MacLean AW, Moldofsky H. Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can J Psychol 1991;45:179-84.
36
Choy EH. The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol 2015;11:513-20.
37
Koca T. Fibromiyaljide Kognitif Disfonksiyon. Aktd 2014;24:105-18.
38
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10:895-926.
39
Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
40
Bhargava J, Hurley JA. Fibromyalgia. [Updated 2023 Jun 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK540974/
41
Meyer HP. Myofascial pain syndrome and its suggested role in the pathogenesis and treatment of fibromyalgia syndrome. Curr Pain Headache Rep 2002;6:274-83.
42
Tzadok R, Ablin JN. Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Res Manag 2020;2020:6541798.
43
Hulens M, Bruyninckx F, Rasschaert R, Vansant G, De Mulder P, Stalmans I, et al. Electrodiagnostic Abnormalities Associated with Fibromyalgia. J Pain Res 2020;13:737-44.
44
Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004;50:613-23.
45
Segerdahl AR, Mezue M, Okell TW, Farrar JT, Tracey I. The dorsal posterior insula subserves a fundamental role in human pain. Nat Neurosci 2015;18:499-500.
46
Napadow V, LaCount L, Park K, As-Sanie S, Clauw DJ, Harris RE. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum 2010;62:2545-55.
47
Harris RE. Elevated excitatory neurotransmitter levels in the fibromyalgia brain. Arthritis Res Ther 2010;12:141.
48
Foerster BR, Nascimento TD, DeBoer M, Bender MA, Rice IC, Truong DQ, et al. Excitatory and inhibitory brain metabolites as targets of motor cortex transcranial direct current stimulation therapy and predictors of its efficacy in fibromyalgia. Arthritis Rheumatol 2015;67:576-81.
49
Sturgill J, McGee E, Menzies V. Unique cytokine signature in the plasma of patients with fibromyalgia. J Immunol Res 2014;2014:938576.
50
Littlejohn G, Guymer E. Neurogenic inflammation in fibromyalgia. Semin Immunopathol 2018;40:291-300.
51
McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 2005;52:3660-9.
52
Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med 2007;146:726-34.
53
Kim SM, Lee SH, Kim HR. Applying the ACR Preliminary Diagnostic Criteria in the Diagnosis and Assessment of Fibromyalgia. Korean J Pain 2012;25:173-82.
54
Dymon TE. Fibromyalgia. In: ACSAP 2015 Book 1—Neurologic and Psychiatric Care. Lenexa, KS: American College of Clinical Pharmacy; 2015:5-18.
55
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 2016;46:319-29.
56
Gyorfi M, Rupp A, Abd-Elsayed A. Fibromyalgia Pathophysiology. Biomedicines 2022;10:3070.
57
Perrot S. Fibromyalgia syndrome: a relevant recent construction of an ancient condition? Curr Opin Support Palliat Care 2008;2:122-7.
58
Culpepper L. Evaluating the patient with fibromyalgia. J Clin Psychiatry 2010;71:e25.
59
Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol 2020;16:645-60.
60
White KP, Speechley M, Harth M, Ostbye T. Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 2000;29:44-51.
61
Yunus MB. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 2007;21:481-97.
62
Bertolucci PH, de Oliveira FF. Cognitive impairment in fibromyalgia. Curr Pain Headache Rep 2013;17:344.
63
Katz RS, Heard AR, Mills M, Leavitt F. The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 2004;10:53-8.
64
Garofalo C, Cristiani CM, Ilari S, Passacatini LC, Malafoglia V, Viglietto G, et al. Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis. Biomedicines 2023;11:1701.
65
Gui MS, Pimentel MJ, Rizzatti-Barbosa CM. Temporomandibular disorders in fibromyalgia syndrome: a short-communication. Rev Bras Reumatol 2015;55:189-94.
66
Cetingok S, Seker O, Cetingok H. The relationship between fibromyalgia and depression, anxiety, anxiety sensitivity, fear avoidance beliefs, and quality of life in female patients. Medicine (Baltimore) 2022;101:e30868.
67
Cruz BA, Catalan-Soares B, Proietti F. Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I. J Rheumatol 2006;33:2300-3.
68
Häuser W, Sarzi-Puttini P, Fitzcharles MA. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin Exp Rheumatol 2019;37 Suppl 116:90-7.
69
Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc 2015;90:680-92.
70
Chinn S, Caldwell W, Gritsenko K. Fibromyalgia Pathogenesis and Treatment Options Update. Curr Pain Headache Rep 2016;20:25.
71
Erdost H. Capsaicin. Uludag Univ J Fac Vet Med 2004;23;1-2-3:149-55.
72
McCarty DJ, Csuka M, McCarthy G, Trotter D. Treatment of pain due to fibromyalgia with topical capsaicin: a pilot study. Semin Arthritis Rheum 1994;23 Suppl:41-7.
73
Gur A, Oktayoglu P. Advances in diagnostic and treatment options in patients with fibromyalgia syndrome. Open Access Rheumatol 2009;1:193-209.
74
Merchant RE, Andre CA. A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis. Altern Ther Health Med 2001;7:79-91.
75
Sohretoglu D, Huang S. Ganoderma lucidum Polysaccharides as An Anti-cancer Agent. Anticancer Agents Med Chem 2018;18:667-74.
76
Collado Mateo D, Pazzi F, Domínguez Muñoz FJ, Martín Martínez JP, Olivares PR, Gusi N, et al. GANODERMA LUCIDUM IMPROVES PHYSICAL FITNESS IN WOMEN WITH FIBROMYALGIA. Nutr Hosp 2015;32:2126-35.
77
Gera M, Sharma N, Ghosh M, Huynh DL, Lee SJ, Min T, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 2017;8:66680-98.
78
Lister RE. An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J Int Med Res 2002;30:195-9.
79
Shakiba M, Moazen-Zadeh E, Noorbala AA, Jafarinia M, Divsalar P, Kashani L, et al. Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial. Avicenna J Phytomed 2018;8:513-23.
80
Barmaki M, Maindet-Dominici C, Nizard J, Baron D, Russ I, Fardellone P, et al. Multicenter, Prospective, Controlled Double-Blind Study Comparing Fib-19-01, A Phytotherapy Treatment, To A Dietary Supplement And To Conventional Care In Patients Suffering From Fibromyalgia. Altern Ther Health Med 2019;25:46-53.
81
Mundy PJ, Ncube SF. Devil’s claw—a natural substitute for diclofenac? Vulture News 2014;67:43-7.
82
Rana MG. 7 Most Effective Herbal Treatments for Fibromyalgia. Fibromyalgia. (15.04.2024). Available from: https://www.fibromyalgiaresources.com/herbal-treatment-fibromyalgia/
83
Shen CL, Schuck A, Tompkins C, Dunn DM, Neugebauer V. Bioactive Compounds for Fibromyalgia-like Symptoms: A Narrative Review and Future Perspectives. Int J Environ Res Public Health 2022;19:4148.
84
Fujishita K, Ozawa T, Shibata K, Tanabe S, Sato Y, Hisamoto M, et al. Grape seed extract acting on astrocytes reveals neuronal protection against oxidative stress via interleukin-6-mediated mechanisms. Cell Mol Neurobiol 2009;29:1121-9.
85
Mun HI, Kim SH, Jang TJ, Moon IS. Analgesic effect of grape seed proanthocyanidin extract in fibromyalgia animal model. J. Life Sci 2010;20:496-502.
86
Edwards AM, Blackburn L, Christie S, Townsend S. Food supplements in the treatment of primary fibromyalgia: a double-blind, crossover trial of anthocyanidins and placebo. J Nutr Environ Med 2009;10:189-99.
87
Jahromi B, Pirvulescu I, Candido KD, Knezevic NN. Herbal Medicine for Pain Management: Efficacy and Drug Interactions. Pharmaceutics 2021;13:251.
88
Beer AM, Wegener T. Willow bark extract (Salicis cortex) for gonarthrosis and coxarthrosis--results of a cohort study with a control group. Phytomedicine 2008;15:907-13.
89
Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987;30:103-14.
90
Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 1989;38:347-52.
91
Zhang Y, Wang C, Wang L, Parks GS, Zhang X, Guo Z, et al. A novel analgesic isolated from a traditional Chinese medicine. Curr Biol 2014;24:117-23.
92
Braz AS, Morais LC, Paula AP, Diniz MF, Almeida RN. Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial. Braz J Psychiatry 2013;35:21-8.
93
Berger AA, Keefe J, Winnick A, Gilbert E, Eskander JP, Yazdi C, et al. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia. Best Pract Res Clin Anaesthesiol 2020;34:617-31.
94
Bjørklund G, Dadar M, Chirumbolo S, Aaseth J. Fibromyalgia and nutrition: Therapeutic possibilities? Biomed Pharmacother 2018;103:531-8.
95
Lowry E, Marley J, McVeigh JG, McSorley E, Allsopp P, Kerr D. Dietary Interventions in the Management of Fibromyalgia: A Systematic Review and Best-Evidence Synthesis. Nutrients 2020;12:2664.
96
Barnish M, Sheikh M, Scholey A. Nutrient Therapy for the Improvement of Fatigue Symptoms. Nutrients 2023;15:2154.
97
Alcocer-Gómez E, Cano-García FJ, Cordero MD. Effect of coenzyme Q10 evaluated by 1990 and 2010 ACR Diagnostic Criteria for Fibromyalgia and SCL-90-R: four case reports and literature review. Nutrition 2013;29:1422-5.
98
Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM, et al. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid Redox Signal 2013;19:1356-61.
99
Shumer G, Warber S, Motohara S, Yajima A, Plegue M, Bialko M, et al. Complementary and alternative medicine use by visitors to rural Japanese family medicine clinics: results from the international complementary and alternative medicine survey. BMC Complement Altern Med 2014;14:360.
100
Nahin RL, Stussman BJ, Herman PM. Out-Of-Pocket Expenditures on Complementary Health Approaches Associated With Painful Health Conditions in a Nationally Representative Adult Sample. J Pain 2015;16:1147-62.
101
Rudrappa GH, Chakravarthi PT, Benny IR. Efficacy of high-dissolution turmeric-sesame formulation for pain relief in adult subjects with acute musculoskeletal pain compared to acetaminophen: A randomized controlled study. Medicine (Baltimore) 2020;99:e20373.
102
Dhingra D, Jangra A. Antiepileptic activity of ellagic acid, a naturally occurring polyphenolic compound, in mice. Journal of Functional Foods 2014;10:364-9.
103
Tripathi SM, Singh VK, Singh S, Singh DK. Enzyme inhibition by the molluscicidal agent Punica granatum Linn. bark and Canna indica Linn. root. Phytother Res 2004;18:501-6.
104
Akbaş MN. Evaluation of pomegranate (Punica Granatum l.) fruitpeels in food, cosmetic and herbal pharmaceuticalindustry (thesis). İstanbul: Bezmialem University. 2021.
105
Borsook D, Sava S, Becerra L. The pain imaging revolution: advancing pain into the 21st century. Neuroscientist 2010;16:171-85.
106
Hackshaw KV. The Search for Biomarkers in Fibromyalgia. Diagnostics (Basel) 2021;11:156.
107
Littlejohn G, Guymer E. Modulation of NMDA Receptor Activity in Fibromyalgia. Biomedicines 2017;5:15.
108
Erdrich S, Hawrelak JA, Myers SP, Harnett JE. Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review. BMC Musculoskelet Disord 2020;21:181.
109
Quaranta G, Guarnaccia A, Fancello G, Agrillo C, Iannarelli F, Sanguinetti M, et al. Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies. Microorganisms 2022;10:2424.
110
Leroux A, Rzasa-Lynn R, Crainiceanu C, Sharma T. Wearable Devices: Current Status and Opportunities in Pain Assessment and Management. Digit Biomark 2021;5:89-102.
